Watanabe Y, Sakai R R, McEwen B S, Mendelson S
Laboratory of Neuroendocrinology, Rockefeller University, New York, NY 10021.
Brain Res. 1993 Jun 25;615(1):87-94. doi: 10.1016/0006-8993(93)91117-b.
The interactions between 14 days of repeated restraint stress and daily administration of imipramine or tianeptine (2 h before the beginning of stress) were investigated in rats to assess responses of 5-HT2 and 5-HT1A receptors and serotonin transporter sites labelled by [3H]paroxetine in the cerebral cortex and hippocampus, two brain regions in which adrenal steroid effects on serotonin receptor-binding have been reported. 5-HT2 sites, labelled by [125I]7-amino-8-iodo ketanserin, were decreased in parietal cerebral cortex layers 3 and 5 by imipramine treatment, but not by tianeptine treatment and not by daily restraint stress. Stress, but not antidepressant, depressed 5-HT1A sites labelled with [3H]8-hydroxy-DPAT in hippocampal fields CA3, CA4 and dentate gyrus. [3H]paroxetine-binding to serotonin transporter sites was decreased by tianeptine treatment as well as by imipramine in both hippocampus and cerebral cortex, with some overlap of the fields that were significantly affected, whereas there were no effects of stress per se and no evidence of a stress x drug interaction. These results are discussed in relation to similarities and differences in the effects of different antidepressant drugs on the serotonergic system of the rat brain. Whereas the actions of imipramine and tianeptine on 5-HT2 and 5-HT1A receptors are specific to each drug, the surprising finding of a similar effect of both drugs to reduce serotonin transporter sites labelled by [3H]paroxetine suggest the possibility of a common action for these two drugs in spite of their opposite effects on serotonin re-uptake.
在大鼠中研究了14天重复束缚应激与每日给予丙咪嗪或噻奈普汀(应激开始前2小时)之间的相互作用,以评估大脑皮层和海马中5-HT2和5-HT1A受体以及由[3H]帕罗西汀标记的5-羟色胺转运体部位的反应,这两个脑区已有关于肾上腺类固醇对5-羟色胺受体结合有影响的报道。用[125I]7-氨基-8-碘酮舍林标记的5-HT2部位,在顶叶大脑皮层第3和第5层中,丙咪嗪治疗使其减少,但噻奈普汀治疗和每日束缚应激未使其减少。应激而非抗抑郁药使海马CA3、CA4区和齿状回中用[3H]8-羟基-DPAT标记的5-HT1A部位减少。噻奈普汀治疗以及丙咪嗪治疗均使海马和大脑皮层中[3H]帕罗西汀与5-羟色胺转运体部位的结合减少,受显著影响的区域有部分重叠,而应激本身无影响,也无应激与药物相互作用的证据。结合不同抗抑郁药对大鼠脑5-羟色胺能系统作用的异同对这些结果进行了讨论。虽然丙咪嗪和噻奈普汀对5-HT2和5-HT1A受体的作用因药物而异,但这两种药物对减少由[3H]帕罗西汀标记的5-羟色胺转运体部位有相似作用,这一惊人发现提示尽管它们对5-羟色胺再摄取有相反作用,但这两种药物可能有共同作用。